
Reset all filters
01 15Gowling WLG (Canada) LLP
Reset all filters
01 32472399
02 62590511
03 62703598
Reset all filters
01 15SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX
Reset all filters
01 15TABLET
Reset all filters
01 32023-01-16
02 62026-11-08
03 62028-11-04
Patent Expiration Date : 2026-11-08
Date Granted : 2013-01-08
Brand Name : SACUBITRIL-VALSARTAN
Patent Number : 2590511
Filing Date : 2006-11-08
Strength per Unit : 24mg / 26mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-11-08
Date Granted : 2013-01-08
Patent Expiration Date : 2028-11-04
Date Granted : 2016-08-09
Brand Name : SACUBITRIL-VALSARTAN
Patent Number : 2703598
Filing Date : 2008-11-04
Strength per Unit : 24mg / 26mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-11-04
Date Granted : 2016-08-09
Patent Expiration Date : 2026-11-08
Date Granted : 2013-01-08
Brand Name : SACUBITRIL-VALSARTAN
Patent Number : 2590511
Filing Date : 2006-11-08
Strength per Unit : 49mg / 51mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-11-08
Date Granted : 2013-01-08
Patent Expiration Date : 2028-11-04
Date Granted : 2016-08-09
Brand Name : SACUBITRIL-VALSARTAN
Patent Number : 2703598
Filing Date : 2008-11-04
Strength per Unit : 49mg / 51mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-11-04
Date Granted : 2016-08-09
Patent Expiration Date : 2026-11-08
Date Granted : 2013-01-08
Brand Name : SACUBITRIL-VALSARTAN
Patent Number : 2590511
Filing Date : 2006-11-08
Strength per Unit : 97mg / 103mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-11-08
Date Granted : 2013-01-08
Patent Expiration Date : 2028-11-04
Date Granted : 2016-08-09
Brand Name : SACUBITRIL-VALSARTAN
Patent Number : 2703598
Filing Date : 2008-11-04
Strength per Unit : 97mg / 103mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-11-04
Date Granted : 2016-08-09
Patent Expiration Date : 2026-11-08
Date Granted : 2013-01-08
Brand Name : ENTRESTO
Patent Number : 2590511
Filing Date : 2006-11-08
Strength per Unit : 24 mg / 26 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-11-08
Date Granted : 2013-01-08
Patent Expiration Date : 2023-01-16
Date Granted : 2012-02-21
Brand Name : ENTRESTO
Patent Number : 2472399
Filing Date : 2003-01-16
Strength per Unit : 24 mg / 26 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-01-16
Date Granted : 2012-02-21
Patent Expiration Date : 2026-11-08
Date Granted : 2013-01-08
Brand Name : ENTRESTO
Patent Number : 2590511
Filing Date : 2006-11-08
Strength per Unit : 49mg / 51mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-11-08
Date Granted : 2013-01-08
Patent Expiration Date : 2023-01-16
Date Granted : 2012-02-21
Brand Name : ENTRESTO
Patent Number : 2472399
Filing Date : 2003-01-16
Strength per Unit : 49mg / 51mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-01-16
Date Granted : 2012-02-21